Follow
Gary G GR Ostroff
Title
Cited by
Cited by
Year
Mechanism by which orally administered β-1, 3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models
F Hong, J Yan, JT Baran, DJ Allendorf, RD Hansen, GR Ostroff, PX Xing, ...
The Journal of Immunology 173 (2), 797-806, 2004
6332004
Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation
M Aouadi, GJ Tesz, SM Nicoloro, M Wang, M Chouinard, E Soto, ...
Nature 458 (7242), 1180-1184, 2009
6122009
Effect of β-glucan from oats and yeast on serum lipids
S Bell, VM Goldman, BR Bistrian, AH Arnold, G Ostroff, RA Forse
Critical reviews in food science and nutrition 39 (2), 189-202, 1999
2921999
β-Glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells
F Hong, RD Hansen, J Yan, DJ Allendorf, JT Baran, GR Ostroff, GD Ross
Cancer research 63 (24), 9023-9031, 2003
2452003
Drug delivery product and methods
GR Ostroff
US Patent 7,740,861, 2010
2132010
Glucan drug delivery system and adjuvant
S Jamas, GR Ostroff, DD Easson Jr
US Patent 5,607,677, 1997
1961997
Characterization of multilayered nanoparticles encapsulated in yeast cell wall particles for DNA delivery
ER Soto, GR Ostroff
Bioconjugate chemistry 19 (4), 840-848, 2008
1932008
Distinct patterns of dendritic cell cytokine release stimulated by fungal β-glucans and toll-like receptor agonists
H Huang, GR Ostroff, CK Lee, JP Wang, CA Specht, SM Levitz
Infection and immunity 77 (5), 1774-1781, 2009
1922009
Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded β-glucan particles
H Huang, GR Ostroff, CK Lee, CA Specht, SM Levitz
MBio 1 (3), 10.1128/mbio. 00164-10, 2010
1812010
Glucan drug delivery system and adjuvant
S Jamas, GR Ostroff, DD Easson Jr
US Patent 5,032,401, 1991
1791991
HTT-lowering reverses Huntington’s disease immune dysfunction caused by NFκB pathway dysregulation
U Träger, R Andre, N Lahiri, A Magnusson-Lind, A Weiss, S Grueninger, ...
Brain 137 (3), 819-833, 2014
1742014
Anti-infective effect of poly-beta 1-6-glucotriosyl-beta 1-3-glucopyranose glucan in vivo
AB Onderdonk, RL Cisneros, P Hinkson, G Ostroff
Infection and immunity 60 (4), 1642-1647, 1992
1661992
β-Glucan microparticles are good candidates for mucosal antigen delivery in oral vaccination
R De Smet, T Demoor, S Verschuere, M Dullaers, GR Ostroff, G Leclercq, ...
Journal of controlled release 172 (3), 671-678, 2013
1562013
Spectrum and mechanisms of inflammasome activation by chitosan
CL Bueter, CK Lee, JP Wang, GR Ostroff, CA Specht, SM Levitz
The Journal of immunology 192 (12), 5943-5951, 2014
1542014
Method for immune system activation by administration of a β (1-3) glucan which is produced by Saccharomyces cerevisiae strain R4
S Jamas, DD Easson Jr, GR Ostroff
US Patent 5,504,079, 1996
1381996
Glucan particles for macrophage targeted delivery of nanoparticles
ER Soto, AC Caras, LC Kut, MK Castle, GR Ostroff
Journal of drug delivery 2012, 2012
1362012
Relative contributions of dectin-1 and complement to immune responses to particulate β-glucans
H Huang, GR Ostroff, CK Lee, S Agarwal, S Ram, PA Rice, CA Specht, ...
The Journal of Immunology 189 (1), 312-317, 2012
1262012
Glucan particles for selective delivery of siRNA to phagocytic cells in mice
GJ Tesz, M Aouadi, M Prot, SM Nicoloro, E Boutet, SU Amano, A Goller, ...
Biochemical Journal 436 (2), 351-362, 2011
1222011
Glucan drug delivery system and adjuvant
S Jamas, GR Ostroff, DD Easson Jr
US Patent 5,741,495, 1998
1151998
Characterization and optimization of the glucan particle-based vaccine platform
H Huang, GR Ostroff, CK Lee, CA Specht, SM Levitz
Clinical and Vaccine Immunology 20 (10), 1585-1591, 2013
952013
The system can't perform the operation now. Try again later.
Articles 1–20